UPDATE: Dicerna Announces License Agreement With Tekmira
November 17, 2014 at 08:09 AM EST
Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR) (TSX:TKM) a leading developer of RNA interference (RNAi) therapeutics, today ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.